Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease

R Najm, EA Jones, Y Huang - Molecular neurodegeneration, 2019 - Springer
Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer's disease (AD),
increasing risk and decreasing age of disease onset. Many studies have demonstrated the …

[HTML][HTML] Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives

F Oceguera-Yanez, SI Kim, T Matsumoto, GW Tan… - Methods, 2016 - Elsevier
The potential use of induced pluripotent stem cells (iPSCs) in personalized regenerative
medicine applications may be augmented by transgenics, including the expression of …

Human iPSC-derived neural models for studying Alzheimer's disease: from neural stem cells to cerebral organoids

M Barak, V Fedorova, V Pospisilova, J Raska… - Stem Cell Reviews and …, 2022 - Springer
During the past two decades, induced pluripotent stem cells (iPSCs) have been widely used
to study mechanisms of human neural development, disease modeling, and drug discovery …

Dissecting the complexities of Alzheimer disease with in vitro models of the human brain

JW Blanchard, MB Victor, LH Tsai - Nature Reviews Neurology, 2022 - nature.com
Alzheimer disease (AD) is the most prevalent type of dementia. It is marked by severe
memory loss and cognitive decline, and currently has limited effective treatment options …

Induced pluripotent stem cell (iPSC)-based neurodegenerative disease models for phenotype recapitulation and drug screening

CY Chang, HC Ting, CA Liu, HL Su, TW Chiou, SZ Lin… - Molecules, 2020 - mdpi.com
Neurodegenerative diseases represent a significant unmet medical need in our aging
society. There are no effective treatments for most of these diseases, and we know …

Nuclear lamina erosion-induced resurrection of endogenous retroviruses underlies neuronal aging

H Zhang, J Li, Y Yu, J Ren, Q Liu, Z Bao, S Sun, X Liu… - Cell reports, 2023 - cell.com
The primate frontal lobe (FL) is sensitive to aging-related neurocognitive decline. However,
the aging-associated molecular mechanisms remain unclear. Here, using physiologically …

Three dimensional human neuro-spheroid model of Alzheimer's disease based on differentiated induced pluripotent stem cells

HK Lee, C Velazquez Sanchez, M Chen, PJ Morin… - PloS one, 2016 - journals.plos.org
The testing of candidate drugs to slow progression of Alzheimer's disease (AD) requires
clinical trials that are lengthy and expensive. Efforts to model the biochemical milieu of the …

iPS cell technologies: significance and applications to CNS regeneration and disease

H Okano, S Yamanaka - Molecular brain, 2014 - Springer
In 2006, we demonstrated that mature somatic cells can be reprogrammed to a pluripotent
state by gene transfer, generating induced pluripotent stem (iPS) cells. Since that time, there …

Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model

HD Rickner, L Jiang, R Hong, NK O'Neill… - Nature …, 2022 - nature.com
The use of iPSC derived brain organoid models to study neurodegenerative disease has
been hampered by a lack of systems that accurately and expeditiously recapitulate …

Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific …

D Maetzel, S Sarkar, H Wang, L Abi-Mosleh, P Xu… - Stem cell reports, 2014 - cell.com
Summary Niemann-Pick type C (NPC) disease is a fatal inherited lipid storage disorder
causing severe neurodegeneration and liver dysfunction with only limited treatment options …